Actuate Therapeutics, Inc. financial data

Symbol
ACTU on Nasdaq
Location
1751 River Run, Suite 400, Fort Worth, TX
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Nov 13, 2024

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 19.5M shares
Common Stock, Shares, Outstanding 19.5M shares
Common Stock, Value, Issued 20 USD
Weighted Average Number of Shares Outstanding, Basic 10.8M shares +632%
Weighted Average Number of Shares Outstanding, Diluted 10.8M shares +632%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 3.76M USD -34.8%
General and Administrative Expense 1.64M USD +129%
Operating Income (Loss) -5.39M USD +16.7%
Nonoperating Income (Expense) -578K USD -520%
Net Income (Loss) Attributable to Parent -5.97M USD +5.79%
Earnings Per Share, Basic -0.55 USD/shares +87.2%
Earnings Per Share, Diluted -0.55 USD/shares +87.2%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 13.5M USD
Assets, Current 14.3M USD
Assets 14.3M USD
Accounts Payable, Current 2.33M USD
Liabilities, Current 8.5M USD
Liabilities 8.9M USD
Retained Earnings (Accumulated Deficit) -126M USD
Stockholders' Equity Attributable to Parent 5.36M USD
Liabilities and Equity 14.3M USD

Popular Metrics

Label TTM Value / Value Unit Change %
Common Stock, Shares Authorized 200M shares
Common Stock, Shares, Issued 19.5M shares
Common Stock, Par or Stated Value Per Share 0 USD/shares
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 13.5M USD +59.7%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares
Additional Paid in Capital 131M USD
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense 566K USD +265%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares